A Low Bar for Some New Antibiotics

March 31, 2014 9:57 PM

33 0

A Low Bar for Some New Antibiotics

The Food and Drug Administration’s efforts to speed approvals of drugs to fight antibiotic-resistant bacteria will be front and center Monday as the agency considers two new antibiotics with possible advantages.

The FDA’s methods to advance new antibiotics so far haven’t generally led to great new drugs, and there has been considerable debate over attempts to speed the approval process. Some antibiotics approved by the agency in recent years have proven to have limited effect, to be toxic—or even in some ca...

Read more

To category page